Convertible Notes vs SAFE vs Priced Equity: What to Know

Every early-stage founder eventually has to pick between three fundamentally different ways to take investor money — a convertible note, a SAFE, or a priced equity round — and the choice shapes control, dilution and future negotiating leverage in ways that aren't obvious from a first read of the term sheet. Here's what actually separates them.

Priced equity: clarity now, more negotiation upfront

A priced equity round means the company's valuation is set at the time of investment, shares are issued immediately at that price, and ownership percentages are known from day one. This is the most straightforward structure conceptually — everyone knows exactly what they own, immediately — but it requires agreeing on a valuation now, which at a genuinely early stage (limited traction, unproven model) can be a harder, more contentious negotiation than either party wants to have.

Priced rounds typically involve more legal documentation and negotiation time upfront, and are more common once a company has enough traction or data to support a defensible valuation conversation — a true seed round with real revenue or growth signals, rather than a pre-seed cheque written on an idea and a team.

Convertible notes: debt now, equity later

A convertible note is technically a loan — it accrues interest and has a maturity date — but it's designed to convert into equity, usually at the next priced round, rather than actually be repaid in cash. It typically includes a valuation cap (a ceiling on the valuation at which it converts, protecting early investors from being diluted by their own early risk-taking) and/or a discount rate (a percentage off the next round's price).

Notes let both sides defer the hard valuation conversation to a later round when there's more data to base it on, while still letting the investment happen now. The trade-off: because it's legally debt, there's a maturity date and, technically, an obligation to repay if conversion never happens — a detail that matters more than founders sometimes appreciate at signing.

SAFEs: the deliberately simpler alternative

A SAFE (Simple Agreement for Future Equity) was designed specifically to strip out the debt characteristics of a convertible note — no interest, no maturity date, just a right to convert into equity at a future priced round, typically with a valuation cap and/or discount similar to a note. It's faster to close, with less negotiation and legal overhead, which is part of why it's become popular for smaller, early cheques where speed matters more than heavily negotiated terms.

The trade-off is less legal protection and fewer negotiated terms overall than a full priced round — appropriate for smaller, earlier cheques from investors comfortable with that simplicity, less so for a larger round where more parties want more specific terms locked in.

Why instrument choice affects more than just paperwork speed

The instrument you choose has real downstream consequences on your cap table and control. Stack multiple notes or SAFEs with different caps and discounts across several small rounds, and the eventual conversion math at your first priced round can get genuinely complex — several investors converting at different effective valuations simultaneously. This is exactly the kind of complexity that needs to be modelled properly rather than discovered at conversion time; our instrument design guidance covers how to structure this so conversion terms remain enforceable and unambiguous.

The instrument doesn't just determine when you get paid — it determines how much of the company you own once everything converts.

How this connects to your cap table

Every note or SAFE you sign is a future dilution event that hasn't happened yet — which makes cap table structuring and dilution modelling essential even before your priced round happens. A clean model of exactly how each instrument converts under different future valuation scenarios tells you — and your existing shareholders — what ownership actually looks like once the next round prices, rather than finding out for the first time when it happens.

Valuation caps and discounts, explained plainly

Both notes and SAFEs typically carry two investor-protective mechanisms, and it's worth understanding what each actually does. A valuation cap sets a ceiling on the valuation at which the instrument converts, regardless of what your next priced round actually values the company at — protecting early investors from being diluted as if they'd invested at a much higher, later-stage valuation. A discount rate gives early investors a percentage reduction off whatever price the next round sets, as a reward for taking on risk earlier than the priced-round investors. Instruments can carry one, both, or occasionally neither — and whichever mechanism applies (typically whichever gives the investor the better outcome, if both are present) determines their actual conversion price once the next round happens.

Founders sometimes agree to a cap without fully modelling what it means for their own dilution at various future valuations — worth doing the maths before agreeing to specific numbers, not after the instrument is signed.

What happens if there's no next priced round

A less-discussed scenario worth understanding: what happens to a note or SAFE if the company never raises a subsequent priced round — perhaps because it reaches profitability and doesn't need to, or because growth doesn't materialise as hoped. Notes, being debt, technically mature and may require repayment or renegotiation if conversion never triggers. SAFEs generally don't have this issue in the same way since they're not debt, but the specific conversion triggers and any fallback provisions still need to be understood at signing, not discovered later when the situation arises unexpectedly.

What Indian founders specifically need to watch for

Instrument choice in India also has regulatory and tax dimensions that don't map exactly onto how these structures work in other markets — FEMA compliance for any foreign investor participation, and the specific treatment of convertible instruments under Indian company law, both need to be factored into the structuring decision, not treated as an afterthought once the commercial terms are agreed. This is a genuine area where getting local structuring advice before you sign matters more than following a template you've seen used elsewhere.

What sophisticated early investors tend to prefer, and why

Experienced angel investors and micro-VCs often have a house preference for one instrument over another, shaped by what's become standard in their specific market and check-size range. This isn't necessarily a signal about your company — it's often just operational preference on their side, driven by what their own fund documentation and reporting processes are built around. It's reasonable to ask an investor their preferred structure early in the conversation rather than assuming, since accommodating a reasonable preference costs you little and can smooth the path to a faster close.

Choosing the right one for your round

For a small, early cheque from an angel or a friendly investor moving fast, a SAFE is usually the pragmatic choice. For a slightly larger bridge round, or investors who want the (limited) additional protection debt structure offers, a convertible note is common. For a round with real traction data behind it — where a valuation conversation is genuinely groundable in numbers — a priced equity round is often worth the additional negotiation time. If you have a term sheet in hand right now and aren't sure which structure is right for your specific situation, that's exactly the moment to get a second opinion before you sign — our term sheet guidance service walks through this clause by clause.